BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12213127)

  • 1. Multiple anchoring of myelopeptides on sequential oligopeptide carriers (SOC(n)): synthesis, conformation and studies in human leukemia cells.
    Keramisanou D; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Mikhailova AA; Strelkov LA
    J Pept Res; 2002 Sep; 60(3):178-85. PubMed ID: 12213127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis and properties of the myelopeptides with differentiating activity].
    Fonina LA; Kudriavtseva EV; Bespalova ZhD; Efremov MA; Mikhaĭlova AA; Kirilina EA
    Bioorg Khim; 2010; 36(4):493-7. PubMed ID: 20823917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tertiary structure of myelopeptides. II. Conformational analysis of Phe-Arg-Pro-Arg-Ile-Met-Thr-Pro, Val-Val-Tyr-Pro-Asp, and Val-Asp-Pro-Pro].
    Ismailova LI; Akhmetov NA; Abbasly RM; Godzhaev NM
    Bioorg Khim; 2005; 31(2):140-6. PubMed ID: 15889787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptides.
    Sakarellos-Daitsiotis M; Tsikaris V; Vlachoyiannopoulos PG; Tzioufas AG; Moutsopoulos HM; Sakarellos C
    Methods; 1999 Sep; 19(1):133-41. PubMed ID: 10525449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
    Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
    Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new helicoid-type sequential oligopeptide carrier (SOC(n)) for developing potent antigens and immunogens.
    Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Vlachoyiannopoulos PG; Tzioufas AG; Moutsopoulos HM
    Vaccine; 1999 Sep; 18(3-4):302-10. PubMed ID: 10506655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The position of the LysN epsilon H2-grafted antigens along the sequential oligopeptide carrier, Ac-(Aib-Lys-Aib-Gly)n (SOCn-II), influences the antibody recognition: application to the Sm main autoimmune epitope.
    Alexopoulos C; Tsikaris V; Rizou C; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vlachoyiannopoulos PG; Moutsopoulos HM
    Biopolymers; 2000 Jul; 54(1):1-10. PubMed ID: 10799976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
    Petrov RV; Mikhaĭlova AA; Fonina LA
    Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential oligopeptide carriers, SOCn, as scaffolds for the reconstitution of antigenic proteins: applications in solid phase immunoassays.
    Sakarellos-Daitsiotis M; Alexopoulos C; Sakarellos C
    J Pharm Biomed Anal; 2004 Mar; 34(4):761-9. PubMed ID: 15019054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human erythrocyte anion-transport protein. Partial amino acid sequence, conformation and a possible molecular mechanism for anion exchange.
    Brock CJ; Tanner MJ; Kempf C
    Biochem J; 1983 Sep; 213(3):577-86. PubMed ID: 6615451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and application of a new class of sequential oligopeptide carriers (SOCn) for multiple anchoring of antigenic peptides--application to the acetylcholine receptor (AChR) main immunogenic region.
    Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Orlewski P; Marraud M; Cung MT; Vatzaki E; Tzartos S
    Int J Biol Macromol; 1996 Oct; 19(3):195-205. PubMed ID: 8910060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelopeptides: isolation and structure].
    Fonina LA; Gur'ianov SA; Efremov MA; Smirnova OV
    Bioorg Khim; 1998 Jun; 24(6):403-7. PubMed ID: 9702349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
    Jezek J; El Ridi R; Salah M; Wagih A; Aziz HW; Tallima H; El Shafie MH; Khalek TA; Ammou FF; Strongylis C; Moussis V; Tsikaris V
    Biopolymers; 2008; 90(3):349-57. PubMed ID: 17549696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spatial structure of myelopeptides: I. Conformational analysis of MP-1, MP-2, and MP-3].
    Akhmetov NA; Ismailova LI; Abbasly RM; Akhmedov NF; Godzhaev NM
    Bioorg Khim; 2005; 31(1):31-8. PubMed ID: 15787211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative, multifunctional sequential oligopeptide carriers Soc(n)-I and SOC(n)-II: functions-technology-perspectives.
    Alexopoulos C; Krikorian D; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C
    Protein Pept Lett; 2005 Aug; 12(6):601-7. PubMed ID: 16101403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid and sialyl-lactose glyco-conjugates: design, synthesis and binding assays to lectins and swine influenza H1N1 virus.
    Zevgiti S; Zabala JG; Darji A; Dietrich U; Panou-Pomonis E; Sakarellos-Daitsiotis M
    J Pept Sci; 2012 Jan; 18(1):52-8. PubMed ID: 22052803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluorescently labeled differentiating myelopeptide-4: specific binding to and penetration into target cells].
    Gur'ianov SA; Kirilina EA; Khaĭdukov SV; Suvorov NI; Molotkovskaia IM; Mikhaĭlova AA
    Bioorg Khim; 2006; 32(6):574-8. PubMed ID: 17180907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new endogenous differentiating factor (myelopeptide-4) for myeloid cells.
    Strelkov LA; Mikhailova AA; Fonina LA; Petrov RV
    FEBS Lett; 2000 Mar; 470(3):281-4. PubMed ID: 10745082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.